In <i>vitro</i> antitumor activity of patulin on cervical and colorectal cancer cell lines.

Mahdi Abastabar, Alireza Akbari, Javad Akhtari, Mohammad Taghi Hedayati, Tahereh Shokohi, Hassan Mehrad‐Majd, Hossein Ghalehnoei, Sina Ghasemi

PubMed · 2017 · 10 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND AND PURPOSE: , and is responsible for mycotoxicosis in animals and humans.There is still not very detailed data about the anti-cancer potency of patulin, but some reports demonstrated that it induces cellular apoptosis and toxicity. MATERIALS AND METHODS: To determine the efficacy of patulin as a therapeutic strategy for cervical and colorectal cancers, we investigated its effects on HeLa,SW-48, and MRC-5 cell lines. Cell lines were exposed to various concentrations of patulin (i.e., 0.5, 1, 2, and 4 µM), then using methyl thiazolyl tetrazolium (MTT) and bromo-2'-deoxyuridine (BrdU) assays, the rates of apoptosis and cell viability were determined. RESULTS: The obtained results showed a significant reduction in cell viability and apoptosis induction in a dose-dependent manner. Among all the cell lines, the highest growth inhibition rate was obtained at the 4 μM concentration of patulin. CONCLUSION: Our results suggested that patulin could significantly decrease tumor growth in human cervical and colorectal cancer models.

References

19